Adalimumab for induction of remission in Crohn's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Adalimumab for Induction of Remission in Crohn's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434401/all/Adalimumab_for_induction_of_remission_in_Crohn's_disease. Accessed 03 October 2024.
Adalimumab for induction of remission in Crohn's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434401/all/Adalimumab_for_induction_of_remission_in_Crohn's_disease. Accessed October 3, 2024.
Adalimumab for induction of remission in Crohn's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434401/all/Adalimumab_for_induction_of_remission_in_Crohn's_disease
Adalimumab for Induction of Remission in Crohn's Disease [Internet]. In: Cochrane Abstracts. [cited 2024 October 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434401/all/Adalimumab_for_induction_of_remission_in_Crohn's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Adalimumab for induction of remission in Crohn's disease
ID - 434401
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434401/all/Adalimumab_for_induction_of_remission_in_Crohn's_disease
DB - Evidence Central
DP - Unbound Medicine
ER -